We are live on
!
Find out more
FLAM
First Light Asset Management Portfolio holdings
AUM
$1.12B
1-Year Est. Return
114.45%
This Fund
S&P 500
This Quarter
Est. Return
+18.27%
1 Year Est. Return
+114.45%
3 Year Est. Return
+266.49%
5 Year Est. Return
+454.92%
10 Year Est. Return
+8,470.94%
AUM
$1.08B
AUM Growth
+$89.3M
(+9%)
Cap. Flow
+$8.65M
Cap. Flow
% of AUM
0.8%
Top 10 Holdings %
Top 10 Hldgs %
53.14%
Holding
94
New
23
Increased
12
Reduced
34
Closed
20
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
+$34.7M |
| 2 |
SCTL
Societal CDMO, Inc. Common Stock
SCTL
|
+$13.5M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$11.4M |
| 4 |
Guardant Health
GH
|
+$9.37M |
| 5 |
SONX
Sonendo, Inc.
SONX
|
+$7.47M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NGM
NGM Biopharmaceuticals, Inc. Common Stock
NGM
|
+$12.5M |
| 2 |
MODN
MODEL N, INC.
MODN
|
+$12.3M |
| 3 |
Mirum Pharmaceuticals
MIRM
|
+$11M |
| 4 |
CareDx
CDNA
|
+$9.36M |
| 5 |
CUTR
Cutera, Inc.
CUTR
|
+$8.94M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 86.01% |
| 2 | Communication Services | 8.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HZNP
26
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $15.6M | 1.45% |
+137,077
| New | +$11.4M |
|
27
Insmed
INSM
$21.4B
| $15M | 1.39% |
748,970
-7,447
| -1% | -$144K |
|
|
SCTL
28
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
| $12.8M | 1.19% |
+8,571,870
| New | +$13.5M |
|
29
BioMarin Pharmaceuticals
BMRN
$11.6B
| $12.5M | 1.16% |
120,941
-2,381
| -2% | -$224K |
|
30
Health Catalyst
HCAT
$154M
| $12.4M | 1.15% |
1,161,995
+12,162
| +1% | +$117K |
|
31
OrthoPediatrics
KIDS
$519M
| $12M | 1.12% |
302,731
-5,997
| -2% | -$250K |
|
|
SONX
32
DELISTED
Sonendo, Inc.
SONX
| $11.8M | 1.1% |
4,185,619
+3,962,226
| +1,774% | +$7.47M |
|
33
Ultragenyx Pharmaceutical
RARE
$2.45B
| $10.9M | 1.01% |
234,299
-219,495
| -48% | -$8.63M |
|
34
MaxCyte
MXCT
$112M
| $7.45M | 0.69% |
1,365,343
+2,800
| +0.2% | +$17.2K |
|
35
Pfizer
PFE
$143B
| $7.26M | 0.67% |
141,761
-5,390
| -4% | -$258K |
|
36
Genmab
GMAB
$17.7B
| $6.79M | 0.63% |
160,263
-1,464
| -0.9% | -$60.3K |
|
37
OptimizeRx
OPRX
$114M
| $6.07M | 0.56% |
361,276
-2,760
| -0.8% | -$47.7K |
|
|
ABCM
38
DELISTED
Abcam PLC
ABCM
| $5.91M | 0.55% |
379,634
-3,923
| -1% | -$61.3K |
|
|
39
Guardant Health
GH
$21.7B
| $5.57M | 0.52% |
+204,804
| New | +$9.37M |
|
40
Castle Biosciences
CSTL
$855M
| $3.8M | 0.35% |
161,604
-1,620
| -1% | -$37.6K |
|
41
Bioventus
BVS
$892M
| $3.59M | 0.33% |
1,376,536
-22,386
| -2% | -$97.7K |
|
|
AKU
42
DELISTED
Akumin Inc
AKU
| $2.56M | 0.24% |
3,564,264
-200,000
| -5% | -$269K |
|
|
MIRO
43
DELISTED
Miromatrix Medical Inc. Common Stock
MIRO
| $1.6M | 0.15% |
534,656
+18,649
| +4% | +$73.2K |
|
44
Simulations Plus
SLP
$369M
| $1.31M | 0.12% |
35,753
-308
| -0.9% | -$13K |
|
45
iShares Russell 2000 Growth ETF
IWO
$14.3B
| $734K | 0.07% |
+3,422
| New | +$750K |
|
46
Humana
HUM
$43.7B
| $455K | 0.04% |
888
-180
| -17% | -$94.6K |
|
47
Elevance Health
ELV
$81.5B
| $454K | 0.04% |
886
-358
| -29% | -$182K |
|
48
Centene
CNC
$30.7B
| $453K | 0.04% |
+5,521
| New | +$451K |
|
49
Integra LifeSciences
IART
$1.29B
| $407K | 0.04% |
+7,261
| New | +$370K |
|
50
Smith & Nephew
SNN
$13.3B
| $406K | 0.04% |
+15,111
| New | +$379K |
|
Similar funds
AIM
MTCM
CNC
C
RIM
CT
SL
HH
First Light Asset Management's Q4 2022 Portfolio in Review
As of Q4 2022, First Light Asset Management held 94 positions worth $1.08B, up 9% from $988M the previous quarter. Its ten largest holdings account for 53% of the portfolio.
First Light Asset Management's Q4 2022 filing shows 23 new, 12 increased, 34 reduced and 20 closed positions. Its largest new stake was Societal CDMO, Inc. Common Stock: 8,571,870 shares worth $12.8M. The largest sale was NGM Biopharmaceuticals, Inc. Common Stock, an estimated $12.5M.
By sector, the portfolio is most concentrated in Healthcare at 86% of assets, down from 86% a quarter earlier, followed by Communication Services.
- First Light Asset Management's largest Q4 2022 buy was Societal CDMO, Inc. Common Stock: 8,571,870 shares worth $12.8M.
- First Light Asset Management added most to Reata Pharmaceuticals, Inc. Class A Common Stock in Q4 2022, an estimated $34.7M increase.
- First Light Asset Management's biggest Q4 2022 reduction was MODEL N, INC., cutting an estimated $12.3M.
- First Light Asset Management fully exited NGM Biopharmaceuticals, Inc. Common Stock in Q4 2022, selling an estimated $12.5M.
- First Light Asset Management's ten largest holdings make up 53% of its $1.08B portfolio in Q4 2022.
- First Light Asset Management opened 23 new positions and closed 20 in Q4 2022.
- First Light Asset Management's portfolio value rose 9% quarter-over-quarter to $1.08B.
Based on First Light Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.